Background: The Diabetes Error Test Model (DETM) has been developed to characterize the clinical relevance of the large and varying margins of error of parameters affecting postprandial blood glucose (BG) levels, which increase the risk for hypo- or hyperglycemia.
Methods: The DETM is based on a treatment concept aimed at normoglycemia after meals. The model includes as parameters (a) preprandial BG measurement by patient self-monitoring (SMBG), (b) patient estimate of carbohydrate amounts (CARB-P) in food, (c) effect of CARB-P on maximum BG increase, (d) effect of insulin on maximum BG decrease, and (e) insulin dosage. Covering the relevant range of preprandial BG (30-330 mg/dl), the DETM simulates the maximum effect of these parameters and their margins of error on postprandial BG values.
Results: According to the DETM, a SMBG error of +20% results in normoglycemia (BG range: 60-160 mg/dl) as the postprandial outcome if preprandial BG values are in the range of 30-130 or 260-330 mg/dl, but can unexpectedly result in hypoglycemia if preprandial BG values are between 131 and 259 mg/dl. If the SMBG error of +20% is combined, e.g., with an error of CARB-P estimate in the food of +20%, hypoglycemia as the postprandial outcome is worsened. If one combines the effects of errors of more than two parameters, even with errors that are so small that they have no clinically relevant dysglycemic effect on postprandial BG per se (e.g., +/-6%), this can result in postprandial hypo- or hyperglycemic values.
Conclusion: The DETM simulates the effects of errors of parameters affecting postprandial BG within the clinically relevant BG range. The DETM offers the opportunity to evaluate the clinical relevance of these errors and their contribution to the increased risk of meal-related excessive glucose excursions during intensified insulin therapy.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2769704 | PMC |
http://dx.doi.org/10.1177/193229680800200109 | DOI Listing |
J Neurogastroenterol Motil
January 2025
Divisions of Pediatric Gastroenterology, Hepatology, and Nutrition, Nationwide Children's Hospital, Columbus, OH, USA.
Background/aims: Pediatric patients with suspected gastroparesis often undergo antroduodenal manometry (ADM) and gastric emptying scintigraphy (GES) for diagnostic purposes. However, it is unknown if delayed gastric emptying (DGE) correlates with manometric findings. This study evaluates whether ADM parameters differ between normal and abnormal GES in pediatric patients.
View Article and Find Full Text PDFAquac Nutr
December 2024
Norwegian Institute of Food, Fisheries and Aquaculture Research (Nofima), Bergen, Norway.
Two short-term feeding trials were conducted on , with the interaction between dietary zinc (Zn) and fat level in trial 1 and with the interaction between dietary Zn and n-3 long-chain polyunsaturated fatty acids (n-3 LC-PUFA) in trial 2, focusing on postprandial plasma parameters, intestinal Zn and fat uptake and transport. After 4-week feeding interventions, samples were collected at different postprandial time points, ranging from 0 to 36/38 h after feeding. Results showed that increased Zn level in feed significantly increased the postprandial plasma Zn level in trial 1 (8-9°C).
View Article and Find Full Text PDFClin Obes
December 2024
Division of Gastroenterology-Hepatology, Maastricht University Medical Center, Maastricht, The Netherlands. NUTRIM-School for Nutrition and Translational Research in Metabolism, Maastricht, the Netherlands.
Background: Bariatric surgery is very effective in long-term weight management. The present study was undertaken to investigate the short-term effects of sleeve gastrectomy (SG) and of Roux-en-Y gastric bypass (RYGB) on (a) gastrointestinal (GI) motility, that is gastric emptying and oro-cecal transit time and (b) secretion of regulatory gut peptides and (c) their interrelationship.
Methods: Prospective single-centre study in which we assessed gastric emptying, oro-cecal transit time and gut peptide release in 28 severely obese individuals before and 2, respectively, 12 months after bariatric surgery (either SG or RYGB).
Clin Diabetes Endocrinol
December 2024
Glenmark Pharmaceuticals, Mumbai, India.
Aims: The ICMR INDIAB-17 study revealed a diabetes prevalence of 11.4% in India, emphasizing the need for effective treatment for glycemic control. A Phase IV study was conducted to evaluate the safety and efficacy of a Fixed Dose Combination (FDC) of Remogliflozin, Metformin and Vildagliptin (RMV) in Type 2 Diabetes Mellitus (T2DM) patients uncontrolled on Metformin plus SGLT2 inhibitor or Metformin plus DPP4 inhibitor dual therapy.
View Article and Find Full Text PDFObes Surg
January 2025
General Surgery Department, Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Background: Obesity is a prevalent metabolic disorder that significantly contributes to insulin resistance (IR), type 2 diabetes (T2DM), and metabolic syndrome. Sleeve gastrectomy has emerged as an effective surgical intervention for obesity, with potential benefits on metabolic health. This study investigates the impact of sleeve gastrectomy on serum insulin levels, IR (HOMA-IR), inflammatory markers, C-peptide, kidney function, and various biochemical parameters in diabetic and non-diabetic patients.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!